Amelioration of intestinal and systemic sequelae of murine Campylobacter jejuni infection by probiotic VSL#3 treatment

Amelioration of intestinal and systemic sequelae of murine Campylobacter jejuni infection by probiotic VSL#3 treatment

Abstract Background The incidence of human Campylobacter jejuni infections is progressively increasing worldwide. Probiotic compounds might open up valuable tools to decrease pathogen burden and subsequent pro-inflammatory immune responses, but in vivo data are scarce. Methods and results Secondary...

Full description

Bibliographic Details
Main Authors: Ira Ekmekciu, Ulrike Fiebiger, Kerstin Stingl, Stefan Bereswill, Markus M. Heimesaat
Format: Article
Language:English
Published: BMC 2017-04-01
Series:Gut Pathogens
Subjects:
Probiotic compound
VSL#3
Secondary abiotic mice
Gnotobiotic mice
Bacterial in vivo competition
Pathogen–commensal bacteria–host interaction
Online Access:http://link.springer.com/article/10.1186/s13099-017-0168-y

Internet

http://link.springer.com/article/10.1186/s13099-017-0168-y

Similar Items